Table 2 Univariate analysis to prognostic factors associates with OS in 5 years
From: High-risk surgical stage 1 endometrial cancer: analysis of treatment outcome
Five years OS | |||
Variable | Number | Event (%) | P value |
Age | |||
<60 | 55 – 51.8 | 12 – 80.4 | 0.96 |
>60 | 51 – 48.2 | 14 – 76.8 | |
Pathological stage | Number % | Number % | |
Stage – IB | 28 – 26.4 | 5 – 82 | 0.53 |
Stage – IC | 78 – 73.6 | 25 – 7 7 | |
Histology grade | Number % | Number % | |
II | 51 – 48.1 | 12 – 84 | 0.58 |
III | 55 – 51.9 | 14 – 73.7 | |
Grade and Pathological stage | Number % | Number % | |
IB G3 | 28 – 26.4 | 5 – 82.3 | 0.43 |
IC G2 | 51 – 48.1 | 12 – 83.9 | |
IC G3 | 27 – 25.5 | 9 – 64.7 | |
First failure site | Number % | Number % | |
No | 76 – 71.6 | 6 – 94.5 | |
loco regional | 8 – 4.7 | 3 – 75.5 | <0.0001 |
Distance | 22 – 20.7 | 17 – 39 | |
Salvage treatment | Number % | Number % | |
Radiotherapy or surgery | 13 – 12.2 | 5 – 77.4 | 0.032 |
chemotherapy | 17 – 16.6 | 15 – 26.1 | |
Lymphadenectomy | Number % | Number % | |
Present | 61 – 37.5 | 6 – 88.7 | 0.047 |
Absent | 45 – 42.5 | 20 – 71,6 | |
Lymphovascular invasion | Number % | Number % | |
Present | 73 – 68.9 | 13 – 71.2 | 0.045 |
Absent | 33 – 31.1 | 13 – 82.2 |